Glenmark Of India, U.K.'s GSK Settle US. Malaria Drug Patent Dispute
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Generics and its U.S. unit said the subsidiary has settled a patent dispute with U.K.-based GlaxoSmithKline over Malarone (atovaquone/proguani) for preventing and treating malaria